[ Price : $8.95]
A Brookings commentary warns that intense price competition in the U.S. generic drug market is undermining manufacturing quality a...[ Price : $8.95]
Ocugen announces positive 12-month results from a mid-stage clinical trial of its experimental gene therapy OCU410, aimed at treat...[ Price : $8.95]
FDA sends a Warning Letter to ImmunityBio, citing misleading promotional claims about its cancer therapy Anktiva (nogapendekin alf...[ Price : $8.95]
FDA grants in part and denies in part an AdvantaPharma petition seeking specific requirements on ANDA holders for generic nintedan...[ Price : $8.95]
FDA requires an updated safety warning for Parkinsons drug products containing carbidopa/levodopa due to their potential to cause ...[ Price : $8.95]
Pfizer and Valneva plan to submit a BLA for their investigational Lyme disease vaccine candidate based on data demonstrating more ...[ Price : $8.95]
A legal update from Wilson Sonsini Goodrich & Rosati addresses FDAs release earlier this month of a draft guidance clarifying the ...[ Price : $8.95]
FDA grants a priority review to an Ionis Pharmaceuticals NDA for zilganersen, an experimental treatment for Alexander disease.